RELATED SERVICE:
Industrial & Manufacturing Markets
Actionable Benefits
- Provides a holistic overview of the pharmaceutical industry to reveal investment priorities.
- Understand the short and mid-term market impacts of COVID-19 on pharmaceutical manufacturers’ technology investments.
- Identify use cases that are driving growth in pharmaceutical manufacturers’ adoption of Industry 4.0 technologies.
- Map the progress made by pharmaceutical clients regarding the utilization of Industry 4.0 technologies on ABI Research’s Digital Maturity Model.
Research Highlights
- Strategic recommendations about engaging with pharmaceutical manufacturers.
- A detailed assessment of spend by pharmaceutical manufacturers on digital technologies through 2030.
- Case studies covering how manufacturers have utilized digital technologies.
- Understand the types of suppliers looking to help pharmaceutical manufacturers digitize processes and optimize production.
Critical Questions Answered
- What are the current and future trends concerning technology adoption by pharmaceutical manufacturers?
- What is the influence of regulators both in terms of compliance and their encouragement of investments in digital technologies?
- What issues inhibit pharmaceutical manufacturers to invest in digital technologies and potential ways they could be overcome?
- Who are some of technology suppliers that focus on addressing the specific needs of pharmaceutical manufacturers?
Who Should Read This?
- Strategists responsible for improving how their organizations engage with the pharmaceutical industry.
- System integrators that need to evaluate potential solutions at their client sites.
- Marketing leaders looking to understand adoption rates for digital technologies.
- Digital leaders at pharmaceutical firms looking to obtain insights covering how digital technologies can support the manufacturing of drugs and vaccines.